Andrew H. Lipsky, Jay N. Lozier, and Adrian Wiestner. 2016. “Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib”. Haematologica 101 (3). Pavia, Italy, e124-e125. https://doi.org/10.3324/haematol.2015.140558.